GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Policyholder Funds

Biosergen AB (OSTO:BIOSGN) Policyholder Funds


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Biosergen AB Business Description

Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a clinical stage biotechnology company advancing the treatment of life-threatening fungal infections. Biosergen' s mission is to develop the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 potential is to eliminate fungal infections rather than just slowing their growth, reducing the risk of resistance.